top of page
Send Us your News and/or Sports Tip:
Search


Vertex Triple Combo, Kaftrio, Approved for CF Patients in EU With F508del Mutation
The European Commission (EC) approved Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor) to treat cystic fi

Jonathan Shar
Aug 25, 20202 min read
11 views
0 comments


First Patients Enrolled in Phase 2b Trial Testing MS1819 for Exocrine Pancreatic Insufficiency in CF
AzurRx BioPharma has enrolled the first three patients in its Phase 2b trial investigating MS1819 as a treatment for exocrine pancreatic ins

Jonathan Shar
Aug 18, 20202 min read
9 views
0 comments


First Participants Dosed in Early Clinical Trial of Inhaled Therapy ARO-ENaC
A Phase 1/2 clinical trial assessing Arrowhead Pharmaceuticals‘ investigational inhaled therapy, ARO-ENaC, for the treatment of cystic fibr

Jonathan Shar
Aug 14, 20202 min read
9 views
0 comments


An Open Letter to the Chronically Ill Professional
It’s easy to look around and compare yourself to your peers. Maybe you didn’t get that promotion because you were sitting in doctors’ app

Jonathan Shar
Aug 4, 20202 min read
7 views
0 comments


Thread-based Wearable Device May Help Diagnose, Monitor CF and Other Conditions
Researchers have developed the first thread-based flexible patch that can be sewn into clothing to monitor — in real-time — several molecule

Jonathan Shar
Jul 31, 20204 min read
14 views
0 comments


Inflammatory Markers May Help Predict Exacerbations in Children with Cystic Fibrosis
Levels of inflammatory markers in the lungs may help predict pulmonary exacerbations in children with cystic fibrosis (CF).

Jonathan Shar
Jul 23, 20203 min read
10 views
0 comments
bottom of page